Duplicate_Summit Medical Group /ID# 213863 — Clifton, New Jersey

Duplicate_Summit Medical Group /ID# 213863 is a clinical research site located in Clifton, New Jersey, United States 07012-1647.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Duplicate_Summit Medical Group /ID# 213863 has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Clifton

Browse all research sites in New Jersey · View every site in Clifton

• New Jersey Physicians
• GSK Investigational Site
• Research Site
• REAL Prevention LLC
• Clifton-Wallington Medical Group
• NJP Clinical Research
• 228
• Care Access - Clifton
• Summit Medical Group
• Pfizer Investigational Site
• Forest Investigative Site 036
• Gastroenterology Associates of New Jersey, LLC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duplicate_Summit Medical Group /ID# 213863?

Duplicate_Summit Medical Group /ID# 213863 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duplicate_Summit Medical Group /ID# 213863 conducted?

Duplicate_Summit Medical Group /ID# 213863 has 1 clinical trials on record. Their work covers Atopic Dermatitis.

Is Duplicate_Summit Medical Group /ID# 213863 accredited by Crixeo Clinical Trials?

Duplicate_Summit Medical Group /ID# 213863 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duplicate_Summit Medical Group /ID# 213863?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.